Milestone Pharmaceuticals (MIST) IPO Opens 4% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall St set to open higher after June jobs report eases rate hike bets
- Oil falls to four-month low as US, Iran conclude talks in Doha
- Bond prices and stocks rally on softer payrolls, dollar falls
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
Milestone Pharmaceuticals Inc. (MIST) Prices Upsized 5.5M Share IPO at $15/Sh
May 9, 2019 6:51 AM EDTMilestone Pharmaceuticals Inc. (NASDAQ: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the pricing of its upsized initial public offering of 5,500,000 of its common shares at a public offering price of $15.00 per... More
